Ecteinascidin-743, a new marine natural product with potent antitumor activity on human ovarian carcinoma xenografts

Clinical Cancer Research

Volumn 4, Issue 8, 1998, Pages 1977-1983

  Valoti, Giorgio ^a   Nicoletti, M Ines ^a   Pellegrino, Antonio ^d   Jimeno, José ^b   Hendriks, Hans ^f   D'Incalci, Maurizio ^e   Faircloth, Glynn ^c   Giavazzi, Raffaella ^a  

^a MARIO NEGRI INST PHARMACOL RES   (Italy)

^b PHARMAMAR S A   (Spain)

^c PharmaMar USA Inc   (United States)

^d SAN GERARDO HOSPITAL   (Italy)

^e MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^f VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; TRABECTEDIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GRAFT; CANCER INHIBITION; CANCER MODEL; CANCER REGRESSION; DRUG EFFECT; FEMALE; HISTOPATHOLOGY; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; NONHUMAN; NUDE MOUSE; OVARY CARCINOMA; PRIORITY JOURNAL; XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL DIVISION; DIOXOLES; DRUG SCREENING ASSAYS, ANTITUMOR; FEMALE; HUMANS; ISOQUINOLINES; MICE; NEOPLASM TRANSPLANTATION; OVARIAN NEOPLASMS; PERITONEAL CAVITY; TETRAHYDROISOQUINOLINES; TRANSPLANTATION, HETEROLOGOUS;

EID: 0031848159     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Kitagawa, I., and Kobayashi, M. Anti-tumor natural products isolated from marine organisms. Gan-To-Kagaku-Ryoho, 16: 1-8, 1989.
2. Kitagawa, I., and Kobayashi, M. Anti-tumor marine natural products. Gan-To-Kagaku-Ryoho, 17: 322-329, 1990.
3. Guan, Y., Sakai, R., Rinehart, K. L., and Wang, A. H. Molecular and crystal structures of ecteinascidins: potent antitumor compounds from the caribbean tunicate Ecteinascidia turbinata. J. Biomol. Struct. Dyn., 10: 793-818, 1993.
4. Jimeno, J. M., Faircloth, G., Cameron, L., Meely, K., Vega, E., Gomez, A., Fernandez Sousa-Faro, J. M., and Rinehart, K. Progress in the acquisition of new marine-derived anticancer compounds: development of ecteinascidin-743 (ET-743). Drugs Fut., 21: 1155-1165, 1996.
5. Eckhardt, S. G., Degen, D., Faircloth, G. T., Jimeno, J., and Von Hoff, D. D. Activity of ecteinascidin, a novel marine cytotoxic, against primary human tumor colony-forming units. Proc Am. Assoc. Cancer Res., 37: 2791, 1996.
6. Rinehart, K. L., Gravalos, L. G., Faircloth, G., and Jimeno, J. ET743: preclinical antitumor development of a marine derived natural product. Proc. Am. Assoc. Cancer Res., 36: 2322, 1995.
7. Hendriks, H. R., Drees, M., Giavazzi, R., Langdon, S. P., Jimeno, J., Fiebig, H. H., and Faircloth, G. High antitumor activity of ET743 in human tumor xenograft models. Proc. Am. Assoc. Cancer Res., 37: 2653, 1996.
8. Pommier, Y., Kohlhagen, G., Bailly, C., Waring, M., Mazumder, A., and Kohn, K. DNA sequence- and structure-selective alkylation of guanine N2 in the DNA minor groove by ecteinascidin 743, a potent antitumor compound from the Caribbean tunicate Ecteinascidia turbinata. Biochemistry, 35: 13303-13309, 1996.
9. D'Incalci, M., Erba, E., Faretta, M., Bergamaschi, D., Guidi, G., Jimeno, J., and Faircloth, G. New drugs of marine origin. Ann. Oncol., 7: 34, 1996.
10. Erba, E., Balconi, G., Faretta, M., Bergamaschi, D., Guidi, G., Jimeno, J., Faircloth, G., and D'Incalci, M. Cell cycle phases perturbations induced by new natural marine compounds. Ann. Oncol., 7: 283, 1996.
11. Garcia-Rocha, M., Garcia-Gravalos, M. D., and Avila, J. Characterisation of antimitotic products from marine organisms that disorganise the microtubule network: ecteinascidin 743, isohomohalichondrin-B and LL-15. Br. J. Cancer, 73: 875-883, 1996.
12. Massazza, G., Tomasoni, A., Lucchini, V., Allavena, P., Erba, E., Colombo, N., Mantovani, A., D'Incalci, M., Mangioni, C., and Giavazzi, R. Intraperitoneal and subcutaneous xenografts of human ovarian carcinoma in nude mice and their potential in experimental therapy. Int. J. Cancer, 44: 494-500, 1989.
13. Boven, E., Winograd, B., Berger, D. P., Dumont, M. P., Braakhuis, B. J. M., Fodstad, O., Langdon, S., and Fiebig, H. H. Phase II preclinical drug screening in human tumor xenografts: a first European multicenter collaborative study. Cancer Res., 52: 5940-5947, 1992.
14. Boven, E., Winograd, B., Fodstad, O., Lobbezoo, M. W., and Pinedo, H. M. Preclinical Phase II studies in human tumor lines: a European multicenter study. Eur. J. Cancer Clin. Oncol., 24: 567-573, 1988.
15. Nicoletti, M. I., Lucchini, V., Massazza, G., Abbott, B. J., D'Incalci, M., and Giavazzi, R. Antitumor activity of Taxol (NSC-125973) in human ovarian carcinomas growing in the peritoneal cavity of nude mice. Ann. Oncol., 4: 151-155, 1993.
16. Dabholkar, M., and Reed, E. Cisplatin. Cancer Chemother. Biol. Response Modif., 16: 88-110, 1996.
17. Moore, B. M., Seaman, F. C., and Hurley, L. H. NMR-based model of an ecteinascidin 743-DNA based. J. Am. Chem. Soc., 119: 5475-5476, 1998.
18. Kristensen, G. B., and Tropé, C. Epithelial ovarian carcinoma. Lancet, 349: 113-117, 1997.
19. Hamilton, T. C., Young, R. C., Louie, K. G., Behrens, B. C., Mckoy, W. M., Grotzinger, K. R., and Ozols, R. F. Characterization of a xenograft model of human ovarian carcinoma which produces ascites and intraabdominal carcinomatosis in mice. Cancer Res., 44: 5286-5290, 1984.
20. KiKuchi, Y., Kizawa, I., Oomori, K., Miyauchi, M., Kita, T., Sugita, M., Tenjin, Y., and Kato, K. Establishment of a human ovarian cancer cell line capable of forming ascites in nude mice and effects of tranexamic acid on cell proliferation and ascites formation. Cancer Res., 47: 592-596, 1987.
21. Ward, B. G., Wallace, K., Shepherd, J. H., and Balkwill, F. R. Intraperitoneal xenografts of human epithelial ovarian cancer in nude mice. Cancer Res., 47: 2662-2667, 1987.
22. Massazza, G., Lucchini, V., Tomasoni, A., Peccatori, F., Lampasona, V., Giudici, G., Mangioni, C., Biondi, A., and Giavazzi, R. Malignant behavior and resistance to cisplatin of human ovarian carcinoma xenografts established from the same patient at different stages of the disease. Cancer Res., 51: 6358-6362, 1991.